Efficacy and Safety Evaluation of Pegamotecan (PEG-camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma

NCT00079950 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

INDUSTRY

Sponsor class

Conditions

Sarcoma, Soft Tissue

Interventions

DRUG: Pegamotecan

Sponsor

Enzon Pharmaceuticals, Inc.